7-117548606-ATGTGTGTG-ATGTGTG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000492.4(CFTR):​c.1210-13_1210-12delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.21 in 1,335,714 control chromosomes in the GnomAD database, including 17,978 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.26 ( 5655 hom., cov: 0)
Exomes 𝑓: 0.20 ( 12323 hom. )

Consequence

CFTR
NM_000492.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0750

Publications

2 publications found
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR-AS1 (HGNC:40144): (CFTR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-117548606-ATG-A is Benign according to our data. Variant chr7-117548606-ATG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 439475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFTRNM_000492.4 linkc.1210-13_1210-12delGT intron_variant Intron 9 of 26 ENST00000003084.11 NP_000483.3
CFTR-AS1NR_149084.1 linkn.222-6069_222-6068delCA intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFTRENST00000003084.11 linkc.1210-34_1210-33delTG intron_variant Intron 9 of 26 1 NM_000492.4 ENSP00000003084.6

Frequencies

GnomAD3 genomes
AF:
0.256
AC:
36639
AN:
143230
Hom.:
5641
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.125
Gnomad AMR
AF:
0.194
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.00103
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.250
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.187
Gnomad OTH
AF:
0.236
GnomAD2 exomes
AF:
0.222
AC:
39472
AN:
177682
AF XY:
0.225
show subpopulations
Gnomad AFR exome
AF:
0.438
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.159
Gnomad EAS exome
AF:
0.0237
Gnomad FIN exome
AF:
0.260
Gnomad NFE exome
AF:
0.270
Gnomad OTH exome
AF:
0.223
GnomAD4 exome
AF:
0.205
AC:
244096
AN:
1192382
Hom.:
12323
AF XY:
0.204
AC XY:
120680
AN XY:
591510
show subpopulations
African (AFR)
AF:
0.422
AC:
13019
AN:
30818
American (AMR)
AF:
0.147
AC:
5570
AN:
37880
Ashkenazi Jewish (ASJ)
AF:
0.150
AC:
2866
AN:
19082
East Asian (EAS)
AF:
0.0186
AC:
621
AN:
33366
South Asian (SAS)
AF:
0.149
AC:
10378
AN:
69468
European-Finnish (FIN)
AF:
0.250
AC:
11099
AN:
44428
Middle Eastern (MID)
AF:
0.219
AC:
1034
AN:
4722
European-Non Finnish (NFE)
AF:
0.210
AC:
189421
AN:
903470
Other (OTH)
AF:
0.205
AC:
10088
AN:
49148
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
9790
19581
29371
39162
48952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6654
13308
19962
26616
33270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.256
AC:
36691
AN:
143332
Hom.:
5655
Cov.:
0
AF XY:
0.252
AC XY:
17562
AN XY:
69656
show subpopulations
African (AFR)
AF:
0.459
AC:
18035
AN:
39292
American (AMR)
AF:
0.193
AC:
2809
AN:
14530
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
338
AN:
3286
East Asian (EAS)
AF:
0.00103
AC:
5
AN:
4846
South Asian (SAS)
AF:
0.108
AC:
478
AN:
4438
European-Finnish (FIN)
AF:
0.250
AC:
2303
AN:
9194
Middle Eastern (MID)
AF:
0.202
AC:
51
AN:
252
European-Non Finnish (NFE)
AF:
0.187
AC:
12108
AN:
64694
Other (OTH)
AF:
0.233
AC:
462
AN:
1986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1196
2393
3589
4786
5982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
240
Bravo
AF:
0.251

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 17, 2018
GeneDx
Significance:Benign
Review Status:flagged submission
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 29, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1210-14_1210-13delTG in intron 9 of CFTR: This variant is not expected to have clinical significance because it has been identified in 47% (582/3375) of Afric an chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinsti tute.org; dbSNP rs3832534).

Cystic fibrosis Benign:2
Jan 29, 2018
CFTR-France
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

the variant does not result in CFTR-RD neither

Dec 17, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 27, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Oct 11, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Other strong data

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.075
La Branchor
0.64
BranchPoint Hunter
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3832534; hg19: chr7-117188660; API